A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Alx Oncology Holdings Inc stock. As of the latest transaction made, Citadel Advisors LLC holds 34,800 shares of ALXO stock, worth $53,244. This represents 0.0% of its overall portfolio holdings.

Number of Shares
34,800
Previous 9,100 282.42%
Holding current value
$53,244
Previous $101,000 106.93%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$5.84 - $17.56 $6.81 Million - $20.5 Million
-1,166,704 Reduced 94.45%
68,511 $413,000
Q1 2024

May 15, 2024

BUY
$10.95 - $16.79 $23,082 - $35,393
2,108 Added 0.17%
1,235,215 $13.8 Million
Q4 2023

Feb 14, 2024

BUY
$4.81 - $15.38 $3.89 Million - $12.4 Million
807,890 Added 189.99%
1,233,107 $18.4 Million
Q3 2023

Nov 14, 2023

BUY
$4.19 - $7.35 $934,093 - $1.64 Million
222,934 Added 110.21%
425,217 $2.04 Million
Q2 2023

Aug 14, 2023

SELL
$4.37 - $9.56 $177,417 - $388,126
-40,599 Reduced 16.72%
202,283 $1.52 Million
Q1 2023

May 15, 2023

BUY
$4.52 - $11.71 $458,929 - $1.19 Million
101,533 Added 71.83%
242,882 $1.1 Million
Q4 2022

Feb 14, 2023

SELL
$9.51 - $12.95 $922,821 - $1.26 Million
-97,037 Reduced 40.71%
141,349 $1.59 Million
Q3 2022

Nov 14, 2022

BUY
$8.23 - $15.14 $1.32 Million - $2.42 Million
160,131 Added 204.63%
238,386 $2.28 Million
Q2 2022

Aug 15, 2022

SELL
$5.89 - $19.46 $328,514 - $1.09 Million
-55,775 Reduced 41.61%
78,255 $633,000
Q1 2022

May 16, 2022

BUY
$13.65 - $22.06 $620,474 - $1 Million
45,456 Added 51.32%
134,030 $2.27 Million
Q4 2021

Feb 14, 2022

SELL
$21.49 - $74.4 $110,566 - $382,788
-5,145 Reduced 5.49%
88,574 $1.9 Million
Q3 2021

Nov 15, 2021

BUY
$52.51 - $80.91 $3.74 Million - $5.76 Million
71,183 Added 315.86%
93,719 $6.92 Million
Q2 2021

Aug 16, 2021

SELL
$52.2 - $75.23 $1.91 Million - $2.76 Million
-36,677 Reduced 61.94%
22,536 $1.23 Million
Q1 2021

May 17, 2021

SELL
$62.84 - $87.68 $14.1 Million - $19.6 Million
-224,043 Reduced 79.1%
59,213 $4.37 Million
Q4 2020

Feb 16, 2021

BUY
$34.11 - $112.26 $9.66 Million - $31.8 Million
283,256 New
283,256 $24.4 Million

Others Institutions Holding ALXO

About ALX ONCOLOGY HOLDINGS INC


  • Ticker ALXO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,747,100
  • Market Cap $62.3M
  • Description
  • ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...
More about ALXO
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.